Specify a stock or a cryptocurrency in the search bar to get a summary
Metacrine Inc
MTCRMetacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California. Address: 3985 Sorrento Valley Boulevard, San Diego, CA, United States, 92121
Analytics
WallStreet Target Price
0.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures MTCR
Dividend Analytics MTCR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
-40 %Dividend History MTCR
Stock Valuation MTCR
Financials MTCR
Results | 2019 | Dynamics |